Home > Insider Trading > Filing (0001209191-20-045395)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1674930	Fulgent Genetics Inc.	FLGT	Services-Medical Laboratories (8071)	812621304

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1819718	Jian Xie	C/O Fulgent Genetics, Inc. 4978 Santa Anita Ave., Ste 205 Temple City CA 91780	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-03	200,000	$0.00	603,712	No	4	A	Direct
Common Stock	Disposition	2020-08-03	1,976	$27.86	601,736	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Reflects an award of restricted stock units relating to 200,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 15, 2020, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019.
The shares were sold in multiple transactions at prices ranging from $27.56 to $28.46, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes toprovide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactionswere effected.